United States Drug Enforcement Administration

Washington, D.C. - Yesterday, a federal jury in Maryland convicted two El Salvadorian nationals for conspiring to participate in La Mara Salvatrucha, a transnational criminal enterprise, commonly known as MS-13. Junior Noe Alvarado-Requeno, aka Insolente, aka Trankilo, 25, and Miguel Angel Corea Diaz, aka Reaper, 39, were convicted of multiple...

Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...

WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...

FORT LAUDERDALE, Fla. – The Drug Enforcement Administration, Department of Defense, and Department of Homeland Security, and U.S. Coast Guard announced today a significant offload of drugs seized in international waters in the Eastern Pacific Ocean and Caribbean Sea. Agents with the DEA and the crew of the USCG Cutter...

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. The Notice of Proposed Rulemaking provides details on the proposed process and was filed for public inspection today, March 20. The...

CORONADO , Calif. – On July 11, 2019, Vice President Mike Pence, Office of National Drug Control Policy Director James W. Carroll, Drug Enforcement Administration Acting Administrator Uttam Dhillon, and Vice Admiral Linda Fagan, commander of Coast Guard Pacific Area, attended a United States Coast Guard drug offload at Naval...

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...